Atherosclerosis is a chronic disease mainly caused by the deposition of cholesterol, fat, and other substances in the arterial walls to form plaques, causing the arterial walls to thicken and harden, ultimately affecting blood flow and causing cardiovascular disease. Lipid-lowering drugs, antiplatelet drugs, and anticoagulants are commonly used clinically to treat atherosclerosis. The most commonly used APIs include aspirin, statins, fibrates, etc.

Protheragen offers a full range of anti-atherosclerotic APIs to support customer research worldwide.